Clinical Trial

FSL2 Post Approval Study for Pediatric and Young Adults Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of the FreeStyle Libre 2 Flash Glucose Monitoring System when used to manage diabetes in pediatric and young adult patient populations.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-07-09; most recent amendment 2026-04-06.
Status change: Recruiting → Active, Not Recruiting 2026-04-06
Trial Details
NCT Number NCT04959552
Lead Sponsor Abbott Diabetes Care
Conditions Diabete Mellitus
Enrollment 550 participants
Start Date 2021-06-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-09